Abstract
Despite the significant recent achievements in the diagnosis and treatment of colorectal cancer (CRC), the prognosis of these patients has currently plateaued. During the past few years, the opportunity to consider multiple treatment modalities (including surgery and other locoregional treatments, systemic therapy, and targeted therapy) led to the research of novel prognostic and predictive biomarkers in CRC liver metastases (CRCLM) patients. In this review, we seek to describe the current state of knowledge of CRCLM biomarkers and to outline impending clinical perspectives, in particular focusing on the cutting-edge tools available for their characterization.
Original language | English |
---|---|
Article number | E3014 |
Journal | International Journal of Molecular Sciences |
Volume | 19 |
Issue number | 10 |
DOIs | |
Publication status | Published - Oct 3 2018 |
Keywords
- biomarkers
- colorectal cancer
- immunohistochemistry
- liver metastases
- molecular markers
- predictive
- prognostic
ASJC Scopus subject areas
- Catalysis
- Molecular Biology
- Spectroscopy
- Computer Science Applications
- Physical and Theoretical Chemistry
- Organic Chemistry
- Inorganic Chemistry